OBJECTIVE: The objective of the study was to investigate whether knowledge of human papillomavirus (HPV) deoxyribonucleic acid test results increases sensitivity of guided cytology screening for the detection of cervical intraepithelial neoplasia (CIN)-2 or higher-grade cervical lesions. STUDY DESIGN: This was a prospective colposcopy-controlled study of 2905 BD SurePath samples to identify cases with CIN2+ within a 24 month follow-up period. Sensitivity and specificity to detect CIN2+ was evaluated, comparing guided cytology screening with and without prior knowledge of HPV status. RESULTS: Prior knowledge of HPV status resulted in significantly higher detection rate of CIN2+ compared with screening blinded to HPV status (P = .005) with limited loss of specificity (P = .026). Gain in sensitivity is higher in older women (43.8%, P = .008) vs in younger women (10.2%, P = .317), whereas loss of specificity is more pronounced in younger women (P < .001) vs older women (P = .729). CONCLUSION: Guided cytological screening performed with prior knowledge of HPV status results in an improved detection of CIN2 or higher-grade lesions.
OBJECTIVE: The objective of the study was to investigate whether knowledge of human papillomavirus (HPV) deoxyribonucleic acid test results increases sensitivity of guided cytology screening for the detection of cervical intraepithelial neoplasia (CIN)-2 or higher-grade cervical lesions. STUDY DESIGN: This was a prospective colposcopy-controlled study of 2905 BD SurePath samples to identify cases with CIN2+ within a 24 month follow-up period. Sensitivity and specificity to detect CIN2+ was evaluated, comparing guided cytology screening with and without prior knowledge of HPV status. RESULTS: Prior knowledge of HPV status resulted in significantly higher detection rate of CIN2+ compared with screening blinded to HPV status (P = .005) with limited loss of specificity (P = .026). Gain in sensitivity is higher in older women (43.8%, P = .008) vs in younger women (10.2%, P = .317), whereas loss of specificity is more pronounced in younger women (P < .001) vs older women (P = .729). CONCLUSION: Guided cytological screening performed with prior knowledge of HPV status results in an improved detection of CIN2 or higher-grade lesions.
Authors: Christine Bergeron; Paolo Giorgi-Rossi; Frederic Cas; Maria Luisa Schiboni; Bruno Ghiringhello; Paolo Dalla Palma; Daria Minucci; Stefano Rosso; Manuel Zorzi; Carlo Naldoni; Nereo Segnan; Massimo Confortini; Guglielmo Ronco Journal: J Natl Cancer Inst Date: 2015-01-07 Impact factor: 13.506
Authors: Christophe E Depuydt; Jef Jonckheere; Mario Berth; Geert M Salembier; Annie J Vereecken; Johannes J Bogers Journal: Cancer Med Date: 2015-05-20 Impact factor: 4.452
Authors: Christophe E Depuydt; Arnold M Criel; Ina H Benoy; Marc Arbyn; Annie J Vereecken; Johannes J Bogers Journal: J Cell Mol Med Date: 2012-12 Impact factor: 5.310
Authors: Mikhail K Ivanov; Sergei E Titov; Sergei A Glushkov; Victoria V Dzyubenko; Anastasia V Malek; Polina A Arkhangelskaya; Roman B Samsonov; Andrey A Mikhetko; Elena V Bakhidze; Igor V Berlev; Nikolay N Kolesnikov Journal: Oncol Rep Date: 2018-01-12 Impact factor: 3.906
Authors: Alex Vorsters; Tine Cornelissen; Elke Leuridan; Johannes Bogers; Davy Vanden Broeck; Ina Benoy; Herman Goossens; Niel Hens; Pierre Van Damme Journal: BMC Public Health Date: 2016-06-07 Impact factor: 3.295
Authors: Kirsten Rozemeijer; Corine Penning; Albert G Siebers; Steffie K Naber; Suzette M Matthijsse; Marjolein van Ballegooijen; Folkert J van Kemenade; Inge M C M de Kok Journal: Cancer Causes Control Date: 2015-10-12 Impact factor: 2.506